NASDAQ:RDNT RadNet (RDNT) Stock Price, News & Analysis → Elon Musk: THIS will be bigger than Tesla (From Paradigm Press) (Ad) Free RDNT Stock Alerts $58.47 -0.28 (-0.48%) (As of 06/14/2024 08:51 PM ET) Add Compare Share Share Today's Range$57.33▼$58.8950-Day Range$46.52▼$61.7552-Week Range$25.11▼$64.06Volume382,600 shsAverage Volume512,922 shsMarket Capitalization$4.32 billionP/E Ratio194.90Dividend YieldN/APrice Target$57.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get RadNet alerts: Email Address RadNet MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside2.1% Downside$57.25 Price TargetShort InterestHealthy4.05% of Shares Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews Sentiment0.21Based on 26 Articles This WeekInsider TradingSelling Shares$5.69 M Sold Last QuarterProj. Earnings Growth8.47%From $0.59 to $0.64 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.16 out of 5 starsMedical Sector320th out of 913 stocksMedical Laboratories Industry9th out of 19 stocks 1.4 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageRadNet has only been the subject of 3 research reports in the past 90 days.Read more about RadNet's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.05% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in RadNet has recently decreased by 4.78%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 2.9 News and Social Media Coverage News SentimentRadNet has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 26 news articles for RadNet this week, compared to 4 articles on an average week.Search Interest4 people have searched for RDNT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows3 people have added RadNet to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,693,287.00 in company stock.Percentage Held by InsidersOnly 5.12% of the stock of RadNet is held by insiders.Percentage Held by Institutions77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about RadNet's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to grow by 8.47% in the coming year, from $0.59 to $0.64 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is 194.90, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 127.03.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is 194.90, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 138.90.Price to Book Value per Share RatioRadNet has a P/B Ratio of 4.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about RadNet's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.See all the details you need here. About RadNet Stock (NASDAQ:RDNT)RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Read More RDNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDNT Stock News HeadlinesJune 16 at 6:12 AM | insidertrades.comInsider Selling: RadNet, Inc. (NASDAQ:RDNT) Director Sells 4,000 Shares of StockJune 14 at 9:54 AM | insidertrades.comAlma Gregory Sorensen Sells 5,000 Shares of RadNet, Inc. (NASDAQ:RDNT) StockJune 14 at 7:12 AM | insidertrades.comRadNet, Inc. (NASDAQ:RDNT) Director Sells $253,799.72 in StockJune 13, 2024 | insidertrades.comRadNet, Inc. (NASDAQ:RDNT) COO Norman R. Hames Sells 15,000 SharesJune 12, 2024 | insidertrades.comRadNet, Inc. (NASDAQ:RDNT) Director Christine Nayoma Gordon Sells 1,500 SharesJune 15 at 1:28 AM | americanbankingnews.comRadNet (NASDAQ:RDNT) Trading Down 6.3% After Insider SellingJune 14 at 5:24 AM | americanbankingnews.comNorman R. Hames Sells 18,597 Shares of RadNet, Inc. (NASDAQ:RDNT) StockJune 14 at 4:34 AM | americanbankingnews.comMark Stolper Sells 25,000 Shares of RadNet, Inc. (NASDAQ:RDNT) StockJune 13, 2024 | americanbankingnews.comDavid Jeffrey Katz Sells 16,400 Shares of RadNet, Inc. (NASDAQ:RDNT) StockJune 12, 2024 | americanbankingnews.comRadNet, Inc. (NASDAQ:RDNT) Director Sells $183,900.00 in StockJune 11, 2024 | globenewswire.comRadNet, Inc. to Present at the Sidoti & Company 2024 Small Cap Conference on Wednesday, June 12thJune 7, 2024 | americanbankingnews.comRadNet (NASDAQ:RDNT) Sets New 1-Year High at $60.78June 7, 2024 | globenewswire.comRadNet, Inc. to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024June 4, 2024 | seekingalpha.comRadNet: Qualified Growth Route, Still UndervaluedJune 3, 2024 | globenewswire.comRadNet, Inc. to Present at the Jefferies 2024 Global Healthcare Conference on June 5, 2024May 13, 2024 | globenewswire.comRadNet, Inc. to Present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2024May 11, 2024 | finance.yahoo.comRadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This YearMay 10, 2024 | insidermonkey.comRadNet, Inc. (NASDAQ:RDNT) Q1 2024 Earnings Call TranscriptMay 10, 2024 | markets.businessinsider.comPeeling Back The Layers: Exploring RadNet Through Analyst InsightsMay 10, 2024 | finance.yahoo.comRadNet, Inc. (NASDAQ:RDNT) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies AheadMay 10, 2024 | finance.yahoo.comRadNet First Quarter 2024 Earnings: Beats ExpectationsMay 10, 2024 | finance.yahoo.comRadNet, Inc. (NASDAQ:RDNT) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?May 9, 2024 | msn.comRadNet GAAP EPS of -$0.04 beats by $0.02, revenue of $431.7M beats by $9.98MMay 8, 2024 | washingtonpost.comRadNet: Q1 Earnings SnapshotMay 8, 2024 | msn.comRDNT Stock Earnings: RadNet Beats Revenue for Q1 2024See More Headlines Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today6/16/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees10,288Year Founded1980Price Target and Rating Average Stock Price Target$57.25 High Stock Price Target$63.00 Low Stock Price Target$48.00 Potential Upside/Downside-2.1%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.30 Trailing P/E Ratio194.90 Forward P/E Ratio99.10 P/E GrowthN/ANet Income$3.04 million Net Margins1.28% Pretax Margin3.35% Return on Equity5.05% Return on Assets1.57% Debt Debt-to-Equity Ratio0.76 Current Ratio1.86 Quick Ratio1.86 Sales & Book Value Annual Sales$1.62 billion Price / Sales2.67 Cash Flow$3.33 per share Price / Cash Flow17.55 Book Value$11.79 per share Price / Book4.96Miscellaneous Outstanding Shares73,880,000Free Float70,097,000Market Cap$4.32 billion OptionableOptionable Beta1.76 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Howard G. Berger M.D. (Age 78)Chairman, President & CEO Comp: $5.56MMr. Mark D. Stolper (Age 53)Executive VP & CFO Comp: $1.13MMr. Mital Patel (Age 38)Executive VP of Financial Planning & Analysis and Chief Administrative Officer Comp: $1.15MMr. Norman R. Hames (Age 68)President & COO of Western Operations Comp: $1.28MMr. Stephen M. Forthuber (Age 63)President & COO of Eastern Operations Comp: $1.3MMs. Christine Nayoma Gordon (Age 60)Senior VP of Operations - Northern California & Director Comp: $384.38kMr. Ranjan Jayanathan (Age 68)Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division Dr. A. Gregory Sorensen M.D. (Age 62)Executive VP, Chief Science Officer & Director Ms. Laura Foster BSRTMPH, J.D., Senior Vice President of Compliance & Regulatory AffairsMr. David Jeffrey Katz (Age 59)Executive VP, Chief Legal Officer & Corporate Secretary More ExecutivesKey CompetitorsGenetronNASDAQ:GTHLaboratory Co. of AmericaNYSE:LHQuest DiagnosticsNYSE:DGXNateraNASDAQ:NTRAExact SciencesNASDAQ:EXASView All CompetitorsInsiders & InstitutionsLawrence L LevittSold 4,000 sharesTotal: $231,080.00 ($57.77/share)Norman R HamesSold 18,597 sharesTotal: $1.17 M ($63.08/share)David L SwartzSold 4,066 sharesTotal: $253,799.72 ($62.42/share)Alma Gregory SorensenSold 5,000 sharesTotal: $306,200.00 ($61.24/share)Mark StolperSold 25,000 sharesTotal: $1.53 M ($61.27/share)View All Insider TransactionsView All Institutional Transactions RDNT Stock Analysis - Frequently Asked Questions Should I buy or sell RadNet stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks. What is RadNet's stock price target for 2024? 4 equities research analysts have issued 1-year price objectives for RadNet's stock. Their RDNT share price targets range from $48.00 to $63.00. On average, they anticipate the company's stock price to reach $57.25 in the next year. This suggests that the stock has a possible downside of 2.1%. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts. How have RDNT shares performed in 2024? RadNet's stock was trading at $34.77 at the beginning of the year. Since then, RDNT shares have increased by 68.2% and is now trading at $58.47. View the best growth stocks for 2024 here. When is RadNet's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our RDNT earnings forecast. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) posted its quarterly earnings results on Wednesday, May, 8th. The medical research company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.16. The medical research company earned $431.70 million during the quarter, compared to analysts' expectations of $421.72 million. RadNet had a trailing twelve-month return on equity of 5.05% and a net margin of 1.28%. RadNet's revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.08) EPS. What ETFs hold RadNet's stock? ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Invesco S&P SmallCap Momentum ETF (XSMO), First Trust Small Cap Growth AlphaDEX Fund (FYC), iShares S&P Small-Cap 600 Growth ETF (IJT), iShares U.S. Healthcare Providers ETF (IHF) and SPDR S&P 600 Small Cap Growth ETF (SLYG). What guidance has RadNet issued on next quarter's earnings? RadNet issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T). Who are RadNet's major shareholders? RadNet's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (6.23%), Principal Financial Group Inc. (2.11%), Hood River Capital Management LLC (1.45%), Global Alpha Capital Management Ltd. (1.38%), Edmond DE Rothschild Holding S.A. (1.19%) and Clearbridge Investments LLC (0.74%). Insiders that own company stock include Alma Gregory Sorensen, Christine Nayoma Gordon, David Jeffrey Katz, David L Swartz, Lawrence L Levitt, Mark Stolper, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RDNT) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
